Peer-reviewed article

Psychedelic drugs for the treatment of substance use disorders.

Sofuoglu M iD, De Aquino JP iD, MacLean RR iD

Expert review of clinical pharmacologyJul 29, 2025United States0 citationsDOI: 10.1080/17512433.2025.2541103

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinKetamineAddiction

Keywords

Alcohol Use DisorderOpioid Use DisorderPsychedelic-assisted Therapy

View paper

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticleKetamine

Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature.

Drozdz SJ, Goel A, McGarr MW +6

Europe PMC2022

ArticleKetamine

Patient Factors Associated With Subanesthetic-Dose Ketamine Infusion in the Postanesthesia Care Unit.

Thomas A, Bazinski M, Michaels B +4

Europe PMC2026

ArticleKetamine

Emergent multiscale organisation of neural dynamics fragments in anaesthesia.

Milinkovic B, Seth AK, Barnett L +2

Europe PMC2026